Hiroyoshi Nishikawa

56PUBLICATIONS
333CO-AUTHORS
Molecular targetsGenome structure and regulationPredictive and prognostic markersAutoimmunityInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Nov 04, 2026
Longitudinal remodeling of the tumor-immune microenvironment during regorafenib, nivolumab, and chemotherapy in advanced gastric cancer.

|Jul 14, 2026
SATB1 preserves CD4+ T-cell fidelity and establishes Treg function in antitumor immunity.

|Apr 27, 2026
Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation.

|Apr 15, 2026
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

|Apr 07, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development.

Yuki Okuhiro, Sachiko Ito, Keisuke Watanabe

|Feb 04, 2026
Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.

Tomoko Kobayashi, Shintaro Iwama, Eri Sugiyama

Pageof 10

Frequent Collaborators

14 joint publications

Shohei Koyama

11 joint publications

Yousuke Togashi

9 joint publications

Kohei Shitara

8 joint publications

Daisuke Sugiyama